Find Arformoterol Tartrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

4 RELATED EXCIPIENT COMPANIES

4EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 200815-49-2, Brovana, (r,r)-arformoterol tartrate, Arformoterol tartrate [usan], 5p8vj2i235, Arformoterol tartrate (usan)
Molecular Formula
C23H30N2O10
Molecular Weight
494.5  g/mol
InChI Key
FCSXYHUNDAXDRH-OKMNHOJOSA-N
FDA UNII
5P8VJ2I235

Arformoterol Tartrate
Arformoterol Tartrate is the tartrate salt of arformoterol, the (R,R)-enantiomer of formoterol and a long-acting beta-2 adrenergic agonist with bronchodilator activity. Arformoterol selectively binds to and activates beta-2 adrenergic receptors in bronchiolar smooth muscle, thereby causing stimulation of adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased intracellular cAMP levels cause relaxation of bronchial smooth muscle and lead to an inhibition of release of inflammatory mediators from mast cells. This may eventually lead to an improvement of airway function.
1 2D Structure

Arformoterol Tartrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,3R)-2,3-dihydroxybutanedioic acid;N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide
2.1.2 InChI
InChI=1S/C19H24N2O4.C4H6O6/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22;5-1(3(7)8)2(6)4(9)10/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22);1-2,5-6H,(H,7,8)(H,9,10)/t13-,19+;1-,2-/m11/s1
2.1.3 InChI Key
FCSXYHUNDAXDRH-OKMNHOJOSA-N
2.1.4 Canonical SMILES
CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.C(C(C(=O)O)O)(C(=O)O)O
2.1.5 Isomeric SMILES
C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
2.2 Other Identifiers
2.2.1 UNII
5P8VJ2I235
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 200815-49-2

2. Brovana

3. (r,r)-arformoterol Tartrate

4. Arformoterol Tartrate [usan]

5. 5p8vj2i235

6. Arformoterol Tartrate (usan)

7. Formamide, N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (2r,3r)-2,3-dihydroxybutanedioate (1:1)

8. (r,r)-formoterol Tartrate

9. (-)-n-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide Hydrogen (2r,3r)-2,3-dihydroxybutanedioate (salt)

10. Formamide, N-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)

11. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-formamide (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)

12. Brovana Inhalation Solution

13. Unii-5p8vj2i235

14. Brovana (tn)

15. Arformotero Ltartrate

16. Dtxsid80173903

17. Arformoterol Tartrate [vandf]

18. S5217

19. Arformoterol Tartrate [mart.]

20. Akos005145740

21. Arformoterol Tartrate [who-dd]

22. Ccg-269651

23. Arformoterol Tartrate, >=98% (hplc)

24. Ba171831

25. Bs-42158

26. Arformoterol Tartrate [orange Book]

27. Formoterol R,r-form L-tartrate [mi]

28. D02981

29. 815f492

30. Q-101035

31. Q27262686

32. (2r,3r)-2,3-dihydroxybutanedioic Acid;n-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide

33. (r,r)-formoterol Tartrate; N-(2-hydroxy-5-((1r)-1-hydroxy-2-(((1r)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide (2r,3r)-2,3-dihydroxybutanedioate (1:1)

34. [(2r)-2-(3-formamido-4-hydroxyphenyl)-2-hydroxyethyl]-[(2r)-1-(4-methoxyphenyl)propan-2-yl]azanium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate

35. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2r,3r)-2,3-dihydroxybutane Dioate

36. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2r,3r)-2,3-dihydroxybutanedioate

37. N-[2-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide L-tartrate

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 494.5 g/mol
Molecular Formula C23H30N2O10
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count11
Rotatable Bond Count11
Exact Mass494.19004516 g/mol
Monoisotopic Mass494.19004516 g/mol
Topological Polar Surface Area206 Ų
Heavy Atom Count35
Formal Charge0
Complexity521
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameBrovana
PubMed HealthArformoterol (By breathing)
Drug ClassesBronchodilator
Active IngredientArformoterol tartrate
Dosage FormSolution
RouteInhalation
Strengtheq 0.015mg base/2ml
Market StatusPrescription
CompanySunovion

2 of 2  
Drug NameBrovana
PubMed HealthArformoterol (By breathing)
Drug ClassesBronchodilator
Active IngredientArformoterol tartrate
Dosage FormSolution
RouteInhalation
Strengtheq 0.015mg base/2ml
Market StatusPrescription
CompanySunovion

5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
beta2-Adrenergic Agonist [EPC]; Adrenergic beta2-Agonists [MoA]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Controlled & Modified Release

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty